Cervical Cancer Diagnostic Tests Market is Expected to Grow at a CAGR of 6.1% from 2014 to 2020

Š2019 Transparency Market Research, All Rights Reserved

Cervical Cancer Diagnostic Tests Market Based on the test types - (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others (Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP Forecast From 2014 - 2020

Š2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

Table of Content Sr. No.

Content

Chapter1

Introduction

Chapter 2

Executive Summary

Chapter 3

Market Overview

Chapter 4

Global Cervical Cancer Diagnostic Tests Market, by Type of Test

Chapter 5

Global Cervical Cancer Diagnostics Tests Market, by Geography

Chapter 6

Recommendations

Chapter 7

Company Profiles

©2019 Transparency Market Research, All Rights Reserved

Cervical Cancer Diagnostic Tests Market: Snapshot •

According to the World Health Organization (WHO), cervical cancer is the second most commonly prevalent cancer and the third greatest cause of death in women, with 530,000 new cases discovered each year.

•

Increasing number of HIV-infected individuals and suppressed immune system are the primary factors contributing to the growth of the global cervical cancer diagnostic tests market.

•

Global cervical cancer diagnostic tests market is segmented based on types of tests performed for the diagnosis of cancer patients.

©2019 Transparency Market Research, All Rights Reserved

©2019 Transparency Market Research, All Rights Reserved

Reports Highlights • Global cervical cancer diagnostic tests market was valued at USD 5.9 billion in 2013 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 8.9 billion in 2020 • Rising Incidence of Cervical Cancer Dialing Growth for Cervical Cancer Diagnostic Tests Market • The growth of segment is mainly attributed to the rising awareness about cancer diagnosis and the high efficacy of the investigation at relatively low costs. HPV testing is expected to register a significant growth rate between 2014 and 2020,

• Key players - Abbott Laboratories, Becton, Dickinson and Company, and Hologic, Inc. Other companies include Guided Therapeutics, Femasys, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.

©2019 Transparency Market Research, All Rights Reserved

Request Sample

Š2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website:

www.transparencymarketresearch.com For sales queries or new topics email us on:

sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030

T

H

A Y

N O

K U